Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents

被引:75
|
作者
Morrey, John D. [1 ]
Olsen, Aaron L. [1 ]
Siddharthan, Venkatraman [1 ]
Motter, Neil E. [1 ]
Wang, Hong [1 ]
Taro, Brandon S. [1 ]
Chen, Dong [2 ]
Ruffner, Duane [2 ]
Hall, Jeffery O. [1 ]
机构
[1] Utah State Univ, Inst Antiviral Res, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA
[2] Utah State Univ, Ctr Integrated Biosyst, Logan, UT 84322 USA
来源
关键词
D O I
10.1099/vir.0.83345-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Blood-brain barrier (BBB) permeability was evaluated in mice and hamsters infected with West Nile virus (WNV, flavivirus) as compared to those infected with Semliki Forest (alphavirus) and Banzi (flavivirus) viruses. BBB permeability was determined by measurement of fluorescence in brain homogenates or cerebrospinal fluid (CSF) after intraperitoneal (i.p.) injection of sodium fluorescein, by macroscopic examination of brains after i.p. injection of Evans blue, or by measurement of total protein in CSF compared to serum. Lethal infection of BALB/c, mice with Semliki Forest virus and Banzi virus caused the brain: serum fluorescence ratios to increase from a baseline of 2-4% to as high as 11 and 15%, respectively. Lethal infection of BALB/c mice with WNV did not increase BIBB permeability. When C57BL/6 mice were used, BBB permeability was increased in some, but not all, of the WNV-infected animals. A procedure was developed to measure BBB permeability in live WNV-infected hamsters by comparing the fluorescence in the CSF, aspirated from the cisterna magnum, with the fluorescence in the serum. Despite a time-dependent tendency towards increased BBB permeability in some WNV-infected hamsters, the highest BBB permeability values did not correlate with mortality. These data indicated that a measurable increase in BBB permeability was not a primary determinant for lethality of WNV infection in rodents. The lack of a consistent increase in BIBB permeability in WNV-infected rodents has implications for the understanding of viral entry, viral pathogenesis and accessibility of the CNS of rodents to drugs or effector molecules.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 50 条
  • [41] Blood-brain barrier permeability and physical exercise
    Marta A. Małkiewicz
    Arkadiusz Szarmach
    Agnieszka Sabisz
    Wiesław J. Cubała
    Edyta Szurowska
    Paweł J. Winklewski
    Journal of Neuroinflammation, 16
  • [42] REGULATION OF PERMEABILITY ACROSS THE BLOOD-BRAIN BARRIER
    Easton, Alexander S.
    BIOLOGY AND REGULATION OF BLOOD-TISSUE BARRIERS, 2013, 763 : 1 - 19
  • [43] Permeability of the blood-brain barrier to neurotrophic viruses
    Friedmann, U
    ARCHIVES OF PATHOLOGY, 1943, 35 (06): : 912 - 931
  • [44] PERMEABILITY OF BLOOD-BRAIN BARRIER IN LYMPHOGENIC ENCEPHALOPATHY
    JOO, F
    ZOLTAN, TO
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1970, 37 (3-4): : 398 - &
  • [45] Permeability of in vitro Blood-Brain Barrier Models
    Li, Guanglei
    Simon, Melissa J.
    Cancel, Limary
    Shi, Zhong-Dong
    Ji, Xinying
    Tarbell, John M.
    Morrison, Barclay, III
    Fu, Bingmei M.
    2010 IEEE 36TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, 2010,
  • [46] Factors influencing the blood-brain barrier permeability
    Zhao, Yibin
    Gan, Lin
    Ren, Li
    Lin, Yubo
    Ma, Congcong
    Lin, Xianming
    BRAIN RESEARCH, 2022, 1788
  • [47] Bioengineering an Artificial Human Blood-Brain Barrier in Rodents
    Kamal, Kimia
    Waldau, Ben
    BIOENGINEERING-BASEL, 2019, 6 (02):
  • [48] A POSSIBLE DETERMINANT OF DRUG ACTION - BLOOD-BRAIN BARRIER
    SHERMAN, GP
    AMERICAN JOURNAL OF PHARMACY, 1970, 142 (03): : 127 - &
  • [49] INCREASED PRODUCTION OF COATED VESICLES IN BRAIN CAPILLARIES DURING ENHANCED PERMEABILITY OF BLOOD-BRAIN BARRIER
    JOO, F
    BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 1971, 52 (06): : 646 - &
  • [50] Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: Establishing a treatment paradigm
    Gerstner, Elizabeth R.
    Fine, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2306 - 2312